Carolina Aguilar is the CEO and Co-Founder of INBRAIN Neuroelectronics, a World Economic Forum Technology Pioneer leading the development of graphene-based brain–computer interfaces. With over 20 years of experience in healthcare, including 13 years at Medtronic heading global neuromodulation and diabetes businesses, she has a proven track record in scaling innovation. Under her leadership, INBRAIN has raised over $100M, achieved FDA Breakthrough Device Designation, and delivered the world’s first graphene neural implant to humans. Passionate about transforming neurotechnology into life-changing therapies, Carolina is shaping the future of precision neuroelectronics worldwide.